1. Adelaide Research & Scholarship

Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-8 of 8 (Search time: 0.001 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2022Methotrexate-related central neurotoxicity: clinical characteristics, risk factors and genome-wide association study in children treated for acute lymphoblastic leukemiaMateos, M.K.; Marshall, G.M.; Barbaro, P.M.; Quinn, M.C.; George, C.; Mayoh, C.; Sutton, R.; Revesz, T.; Giles, J.E.; Barbaric, D.; Alvaro, F.; Mechinaud, F.; Catchpoole, D.; Lawson, J.A.; Chenevix-Trench, G.; MacGregor, S.; Kotecha, R.S.; Dalla-Pozza, L.; Trahair, T.N.
2021CKLF and IL1B transcript levels at diagnosis are predictive of relapse in children with pre‐B‐cell acute lymphoblastic leukaemiaFitter, S.; Bradey, A.L.; Kok, C.H.; Noll, J.E.; Wilczek, V.J.; Venn, N.C.; Law, T.; Paisitkriangkrai, S.; Story, C.; Saunders, L.; Dalla Pozza, L.; Marshall, G.M.; White, D.L.; Sutton, R.; Zannettino, A.C.W.; Revesz, T.
2015Bone marrow recovery by morphometry during induction chemotherapy for acute lymphoblastic leukemia in childrenNguyen, T.; Melville, A.; Nath, S.; Story, C.; Howell, S.; Sutton, R.; Zannettino, A.; Revesz, T.; Bandapalli, O.
2014Outcome of central nervous system relapses in childhood acute lymphoblastic leukaemia - prospective open cohort analyses of the ALLR3 trialMasurekar, A.; Parker, C.; Shanyinde, M.; Moorman, A.; Hancock, J.; Sutton, R.; Ancliff, P.; Morgan, M.; Goulden, N.; Fraser, C.; Hoogerbrugge, P.; Revesz, T.; Darbyshire, P.; Krishnan, S.; Love, S.; Saha, V.; Baer, M.
2022Prospective longitudinal evaluation of treatment-related toxicity and health-related quality of life during the first year of treatment for pediatric acute lymphoblastic leukemiaSchilstra, C.E.; McCleary, K.; Fardell, J.E.; Donoghoe, M.W.; McCormack, E.; Kotecha, R.S.; Lourenco, R.D.A.; Ramachandran, S.; Cockcroft, R.; Conyers, R.; Cross, S.; Dalla-Pozza, L.; Downie, P.; Revesz, T.; Osborn, M.; Alvaro, F.; Wakefield, C.E.; Marshall, G.M.; Mateos, M.K.; Trahair, T.N.
2016Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemiaIrving, J.; Enshaei, A.; Parker, C.; Sutton, R.; Kuiper, R.; Erhorn, A.; Minto, L.; Venn, N.; Law, T.; Yu, J.; Schwab, C.; Davies, R.; Matheson, E.; Davies, A.; Sonneveld, E.; Den Boer, M.; Love, S.; Harrison, C.; Hoogerbrugge, P.; Revesz, T.; et al.
2017High prevalence of relapse in children with Philadelphia-like acute lymphoblastic leukemia despite risk-adapted treatmentHeatley, S.L.; Sadras, T.; Kok, C.H.; Nievergall, E.; Quek, K.; Dang, P.; McClure, B.; Venn, N.; Moore, S.; Suttle, J.; Law, T.; Ng, A.; Muskovic, W.; Norris, M.D.; Revesz, T.; Osborn, M.; Moore, A.S.; Suppiah, R.; Fraser, C.; Alvaro, F.; et al.
2014The optimal use of PEG-Asparaginase in relapsed ALL-Lessons from the ALLR3 clinical trialMasurekar, A.; Fong, C.; Hussein, A.; Revesz, T.; Hoogerbrugge, P.; Love, S.; Ciria, C.; Parker, C.; Krishnan, S.; Saha, V.

Discover